Disease clusters continue to concern the public, and public sentiment that environmental causes are responsible and must be investigated is widely prevalent. More than a decade ago, the Centers for Disease Control and Prevention (CDC) recognized the need to develop operating procedures for response to public concern about disease clusters. The National Conference on Clustering of Health Events was held 15--16 February 1989 in Atlanta, Georgia; the proceedings were published ([@b70-ehp0115-000165]); and the CDC released the "Guidelines for Investigating Clusters of Health Events" ([@b18-ehp0115-000165]) in which a four-stage process was presented: *a*) an initial response to gather source information, *b*) an assessment of the occurrence of the health event, *c*) a feasibility study, and *d*) an epidemiologic investigation. During the last 15 years, these guidelines have provided a framework that most state health departments have adopted, modifying it for their specific situations and available resources. The states have the primary responsibility for response to cancer cluster concerns within their domain. The CDC guidelines emphasize the need for health agencies to develop an approach that maintains community relations while responding to clusters efficiently; the approaches vary among states as well as according to the nature of the cluster and the availability of case and comparison data. The orientation of each state-based inquiry response and investigation plan is shaped by state philosophy and experience with previous clusters.

The purpose of this article is not to revise the CDC guidelines; they retain their usefulness and validity. However, in the past 15 years, numerous cluster studies \[[@b8-ehp0115-000165]; [@b15-ehp0115-000165]; [@b32-ehp0115-000165]; [@b52-ehp0115-000165]; [@b58-ehp0115-000165]; [@b62-ehp0115-000165]; [@b72-ehp0115-000165]\] as well as scientific and technologic developments have affected cluster science and response. Thus, we offer an addendum for use with the original document. Included in this list of significant developments are improvements in cancer registries, a federal initiative in environmental public health tracking (EPHT), refinement of biomarker technology, new cluster identification and geographic information systems (GIS) software, and the emergence of the Internet. These developments have shaped the approach of the CDC National Center for Environmental Health (NCEH) for public health response to cancer clusters.

Role of the CDC/NCEH in Cancer Cluster Response
===============================================

Over the past several decades, industrialization and urban growth have increased human exposure to numerous toxic substances, and as a result, concern has been raised about their relationship to the etiology of chronic disease. The association between environmental factors and disease was validated in recent studies demonstrating that environmental factors such as tobacco smoke, toxic chemicals, dietary habits, and viral infections significantly increase the risk for several types of cancer ([@b48-ehp0115-000165]; [@b86-ehp0115-000165]). A call for increased attention directed toward investigation of environmental exposure as a cause of chronic disease has been widely voiced in the media, the political establishment, and scientific forums.

NCEH defines a cancer cluster as a greater-than-expected number of cancer cases that occurs within a group of people in a geographic area over a defined period of time. In 2000, representatives from the CDC Division of Cancer Prevention and Control (DCPC), National Institute for Occupational Safety and Health (NIOSH), ATSDR, and NCEH met and recognized the importance of a centrally coordinated cancer cluster response to inquiries within the CDC. They assigned this responsibility to NCEH. The rationale for this decision was the strong public perception that environmental exposures are directly responsible for cancer. NCEH now provides a centralized coordinated response system for cancer cluster inquiries received by the CDC. Since the inception of this new responsibility, NCEH has initiated several cluster-related activities ([Table 1](#t1-ehp0115-000165){ref-type="table"}).

Cancer Cluster Public Inquiry Triage System
-------------------------------------------

In 2002, NCEH initiated a centralized inquiry system within the CDC, the Cancer Cluster Public Inquiry Triage System (CCPITS; [@b22-ehp0115-000165]) for responding to cancer cluster inquiries from various audiences such as individual citizens, state health departments, and other federal agencies ([Figure 1](#f1-ehp0115-000165){ref-type="fig"}). The goals of the system are to *a*) provide individual, targeted responses to the public in a timely manner, *b*) decrease the chances of an inquirer having to contact multiple agencies, and *c*) increase communication about cancer clusters among the participating agencies. The response from NCEH to individuals includes basic information on cancer clusters, response to the specific cancer cluster concern, referral to the appropriate state health department and state cancer registry contacts, and links to additional information. NCEH also notifies the state contacts of the inquiry and response. The NCEH cancer cluster website (<http://www.cdc.gov/nceh/clusters>; [@b22-ehp0115-000165]) was developed and designed to support the inquiry system and to facilitate information sharing among federal, state, and local agencies; it provides the cornerstone for the cancer cluster inquiry system. If the inquiry concerns a hazardous waste site, work site, or basic cancer issue, NCEH triages the inquiry to ATSDR, CDC/NIOSH, or DCPC, respectively. NCEH tracks inquiry information via an ACCESS database (Microsoft Corp., Redmond, WA) and communication among CDC programs, federal, state, and local agencies is improved as a result of this single point of contact. Since the inception of the system through July 2005, the cancers of concern most frequently cited by inquirers were breast cancer, leukemia, brain cancer, lung cancer, and colorectal cancer. NCEH uses this information proactively to develop additional tools to better serve the needs of inquirers.

When contacted about a potential cancer cluster, NCEH defers to state health departments to provide the first level of response. States examine their cancer registry data, enabling comparison between incidence rates at various geographic levels. State agencies are in the best position to do this because they maintain data on population demographics, local health and environmental issues, and previous investigations. NCEH becomes involved when state health departments request assistance. Several have requested assistance from NCEH pertaining to cancer clusters. NCEH response has ranged from consultation with appropriate staff to active participation in an epidemiologic or biosampling investigation. In some cases, NCEH has provided assistance by conducting analysis of biological samples and storing them for future study, as it did in the childhood leukemia clusters in Churchill County, Nevada ([@b19-ehp0115-000165]; [@b72-ehp0115-000165]) and Sierra Vista, Arizona ([@b15-ehp0115-000165]).

Media survey of cancer cluster reports
--------------------------------------

Because the media plays a large role in shaping public perception of cancer as well as community concerns about cancer, NCEH conducted a descriptive study of cancer cluster reports in the popular media and characterized the media reports retrieved. A systematic search of newspaper articles on cancer clusters was performed using DIALOG (<http://www.dialog.com/sources/subject>) and NEXIS (<https://www.lexis.com/research>) databases. Media reports were categorized according to the specific incident reported and characterized across several variables, including date, state, number of citations, and perceived environmental exposure ([Figure 2](#f2-ehp0115-000165){ref-type="fig"}). The search produced a media record database containing 1,440 records of approximately 175 suspected cancer cluster reports for the period 1977 through 2001. These data reflect the environmental complexities associated with cancer cluster epidemiology as well as the breadth of popular concern and awareness regarding issues of exposure types, pollution sites, and specific environmental chemicals.

In attempting to report on issues of importance to the public, such as the relationship of apparent disease clusters to environmental exposures, the media may occasionally and perhaps unwittingly misrepresent scientific issues and information ([@b11-ehp0115-000165]; [@b61-ehp0115-000165]). The attempt of the media to focus on human interest, conflicting information, blame, and political symbolism may not always be conducive to the presentation of correct and unbiased information ([@b30-ehp0115-000165]). In addition the relationship between the environment and disease, and the science underlying cluster investigation (e.g., definition of geographic boundaries, calculation of expected rates of disease, population demographics, etiology of cancer, statistical issues) are complex topics and can be difficult for persons without scientific education and training to comprehend ([@b88-ehp0115-000165]). Thus, the media, whether electronic, print, or other format, has both a critical role and a significant opportunity in the presentation of information surrounding cluster investigations.

State-specific activities
-------------------------

In 2001, NCEH conducted a survey to assess state protocols for responding to cancer cluster inquiries and state criteria for conducting investigations. This survey was part of an effort to define and describe existing state-based activities concerning suspected cancer clusters, identify gaps in current investigation methods, and examine opportunities for increasing the efficiency and utility of state and federal efforts. The survey instrument, developed by NCEH, was distributed to 56 states and territories (50 states plus the District of Columbia, Guam, American Samoa, Puerto Rico, the Federated States of Micronesia, and the U.S. Virgin Islands). Although the results of the survey indicated considerable variation among protocols, as well as their perspectives and experiences in cancer cluster investigations, every state or territory that completed the survey (89% participation rate) provided education concerning cancer and/or cancer clusters to all inquirers as part of their inquiry response. Criteria commonly used to determine whether to proceed toward a more intense level of investigation of a cluster included

-   identification of a single cancer type;

-   biological plausibility and adequate latency; for the reported cancer;

-   political pressure;

-   identification of a common cancer in an unusual age group;

-   identification of a rare cancer;

-   identification of exposure to a carcinogenic substance;

-   elevated ratio of observed/expected confirmed cancer cases.

To understand further the experiences of state health departments during recent cancer cluster investigations, NCEH conducted site visits to four states (New Jersey, Arizona, Massachusetts, Ohio) in which there were in-depth investigations of leukemia in circumscribed areas, documented protocols for handling cluster inquiries, and considerable experience and expertise in the investigation of disease clusters.

NCEH also sponsored two workshops during which representatives from 10 states (Massachusetts, Florida, California, South Carolina, Montana, New York, Georgia, Minnesota, Texas, and Washington) met and discussed cancer cluster activity. From these workshops and site visits, several conclusions were drawn. All states and territories placed a high importance on educational components and provided education to all callers. In addition most had standardized forms to facilitate information gathering, took a systematic approach, triaged incoming inquiries, were interested in improved science and methodology, followed the framework suggested by the 1990 CDC guidelines ([@b18-ehp0115-000165]), and had cancer cluster websites. However, response varied greatly depending upon state experience and political considerations. All states and territories were well aware of the inherent complexities in cancer cluster investigations, including data quality, migration, latency, small numbers, and political issues. Most protocols were continuing to evolve.

The states and territories listed several needs during the workshops:

-   validation from a federal agency;

-   additional funding and personnel;

-   training (e.g., CDC-sponsored workshops on methods and media relations);

-   CDC-facilitated information/data sharing;

-   assistance with complex investigations.

Details of the workshop proceedings may be found at <http://www.cdc.gov/nceh/clusters/cluster_response.htm> ([@b20-ehp0115-000165]).

In 2003 in response to a recommendation voiced at the workshop, NCEH established an electronic listserver ([@b21-ehp0115-000165]) to facilitate dialogue among the states and federal agency staff and to provide a mechanism to share and discuss data and scientific methods.

Beginning in 2001, the CDC became involved in two childhood leukemia cluster investigations at the request of state and local health departments. As part of these two cross-sectional exposure assessments in Churchill County, Nevada ([@b19-ehp0115-000165]; [@b72-ehp0115-000165]), and Sierra Vista, Arizona ([@b15-ehp0115-000165]), the CDC conducted detailed laboratory analyses of biological samples.

Recent Environmental Health Initiatives That Impact Cluster Response
====================================================================

Public demand for the investigation of the relationship between environmental exposure and disease has produced a number of significant technologic and programmatic advancements, especially in data collection (cancer/chronic disease registries), data quality (exposure analysis and biomonitoring), and data analysis (statistical methods in spatiotemporal analysis and GIS). Progress in each of these areas has the potential to improve the efficacy of future cancer cluster studies.

Data collection
---------------

Registries provide useful information to estimate disease incidence and prevalence, evaluate epidemics and disease spread, monitor control and prevention measures, detect changes in health practices, recognize newly emerging diseases, maintain a historical archive of data, and facilitate epidemiologic research ([@b43-ehp0115-000165]; [@b50-ehp0115-000165]; [@b82-ehp0115-000165]; [@b83-ehp0115-000165]). Implementation of surveillance measures also serves to increase public confidence in the commitment of the government to protect public health ([@b34-ehp0115-000165]).

Although national disease registries and surveillance programs were initially designed for infectious disease monitoring, the use of registries for chronic disease surveillance has gained increased popularity and funding over the last several decades. ([@b10-ehp0115-000165]; [@b43-ehp0115-000165]; [@b85-ehp0115-000165]). To detect elevated chronic disease levels and to implement appropriate prevention programs, it is important to establish a baseline for disease occurrence. This requires extensive registry-based databases about disease occurrence under "usual" conditions ([@b71-ehp0115-000165]). An increasing number of registries have been established to track chronic adverse health effects, with cancer registries emerging as a gold standard in chronic disease surveillance. ([@b43-ehp0115-000165]; [@b51-ehp0115-000165]; [@b84-ehp0115-000165]).

The NCI initiated the Surveillance Epidemiology and End Results (SEER) program in 1973 to serve as an authoritative source of information on cancer incidence and survival in the United States ([@b59-ehp0115-000165]). SEER now provides cancer surveillance for 26% of the U.S. population ([@b99-ehp0115-000165]). In 1992 the U.S. Congress passed the [@b14-ehp0115-000165], which called for the enhancement of existing statewide cancer registries and authorized a centralized cancer registry program to cover those states not enrolled in SEER. As a result of this congressional act, the CDC implemented the National Program of Cancer Registries (NPCR; <http://www.cdc.gov/cancer/npcr/index.htm>; [@b25-ehp0115-000165]). NPCR complements SEER programs by supporting statewide cancer registries in 45 states, the District of Columbia, and three U.S. territories. Together, SEER and NPCR cover approximately 96% of the U.S. population ([@b99-ehp0115-000165]). Registry certification for SEER and NPCR is provided by the North American Association of Central Cancer Registries ([@b57-ehp0115-000165]), which provides guidance to all state registries to achieve data content and compatibility levels acceptable for pooling data and improving national estimates. Since the publication of the 1990 guidelines ([@b18-ehp0115-000165]), state and regional cancer registries have developed significantly with respect to registry numbers, capacity, and standardization. As a result, cancer registry data will provide high-quality, timely information to support response to concerned communities and facilitate proactive early detection and remediation, especially for cancers with short latency periods ([@b28-ehp0115-000165]; [@b43-ehp0115-000165]; [@b67-ehp0115-000165]; [@b83-ehp0115-000165]).

An important initiative that will impact the work of the CDC in cancer clusters is the development of a national EPHT network. In September 2000, the Pew Environmental Health Commission recommended the creation of a coordinated public health system to track diseases and environmental exposures and to identify environmental health threats ([@b29-ehp0115-000165]). In response, the U.S. Congress funded the CDC in 2002 to begin the development of an EPHT network that would link information on environmental hazards, human exposures to those hazards, and health effects potentially related to those hazards ([@b51-ehp0115-000165]). The goal of this initiative is to integrate hazard monitoring, exposure surveillance, and health effects surveillance into a cohesive national EPHT network. Information gained from this network can be used to respond to and reduce the burden of environment-related disease. Partners in this effort include federal, state, and local health and environmental agencies, nongovernmental organizations, academic institutions, health care organizations, and community groups and members. As a result of this program, geographic areas and populations likely to be affected by environmental contamination will be identifiable, and communities can be provided with valuable information on their environment and potential health implications.

Data quality
------------

Until recently, measurements of human exposure to toxins were usually extrapolated from data collected by environmental sampling, personal interview, or exposure modeling ([@b49-ehp0115-000165]; [@b78-ehp0115-000165]). Efforts have recently shifted toward the development of a wide array of biological markers that can directly determine the portion of a given chemical that enters the body and at what level it can cause damage or disease ([@b27-ehp0115-000165]; [@b75-ehp0115-000165]; [@b77-ehp0115-000165]). Biomarkers of exposure, effect, and susceptibility are currently measured in a variety of biological substances, including blood (serum and peripheral blood lymphocytes), urine, breast milk, feces, adipose tissue, hair, nails, semen, exhaled breath, and buccal, nasal, or bronchial epithelia ([@b9-ehp0115-000165]; [@b77-ehp0115-000165]).

Approximately 300 chemicals can currently be assayed by the NCEH Division of Laboratory Sciences ([@b23-ehp0115-000165]), including polychlorinated biphenyls, dioxins, persistent and nonpersistent organic pesticides and their metabolites, polyaromatic hydrocarbon metabolites, metals, volatile organic compounds, and phytoestrogens. As part of the National Health and Nutrition Examination Survey (NHANES), the public health survey conducted by the CDC National Center for Health Statistics ([@b77-ehp0115-000165]), biological samples collected from thousands of U.S. residents are tested for numerous environmental chemicals. The resulting data are used to compile the *CDC National Report on Human Exposure to Environmental Chemicals*. This report is published every 2 years; the 2005 report includes 148 compounds ([@b24-ehp0115-000165]). NHANES biomonitoring provides baseline exposure data for a number of substances not previously monitored and has been an important comparative tool in the assessment of chemical exposures.

Data analysis: available software and calls for guidance
--------------------------------------------------------

An appendix to the [@b18-ehp0115-000165] disease cluster guidelines presented an exhaustive summary of available methods to test for spatial and/or temporal clustering ([@b18-ehp0115-000165]). Although these methods remain valid and actively used in cluster investigations, many have limited application in cancer cluster analysis because of the associated complexities: long latency period, multiple exposures, genetic susceptibility, migration, small area investigations with limited case numbers, and data quality and resolution ([@b28-ehp0115-000165]; [@b38-ehp0115-000165]; [@b44-ehp0115-000165]; [@b92-ehp0115-000165]; [@b96-ehp0115-000165]). Recognizing these limitations, scientists have refined existing methods and developed additional ones. The topic has been the subject of lively discussion in the literature ([@b26-ehp0115-000165]; [@b41-ehp0115-000165]; [@b94-ehp0115-000165]; [@b95-ehp0115-000165]; [@b97-ehp0115-000165]). Several national and international workshops have also addressed this issue: the 1992 Workshop on "Statistics and Computing in Disease Clustering" in Port Jefferson, New York; the 1994 Conference on "Statistics and Computing in Disease Clustering" sponsored by the NCI in Vancouver, British Columbia, Canada; and the 1997 World Health Organization "Disease Mapping and Risk Assessment for Public Health" in Rome, Italy ([@b40-ehp0115-000165], [@b39-ehp0115-000165]; [@b46-ehp0115-000165]; [@b93-ehp0115-000165]). As a result of the increased intensity in the field of cluster statistics, more than 100 analytic methods are currently available ([@b55-ehp0115-000165]).

A number of software programs and packages, from both private and public sectors, have been developed to service the needs of the public health cluster response community ([Table 2](#t2-ehp0115-000165){ref-type="table"}). The choice of method is determined by ease of use, user familiarity, and funds available for software, updates, and training ([@b41-ehp0115-000165]; [@b96-ehp0115-000165]; [@b97-ehp0115-000165]). To address the issue of appropriate use of methodology in cancer cluster analysis, expert panels have been organized and have provided concise and practical guidance on choice of clustering methods and software. For example, during the 2002 North American Association of Central Cancer Registries GIS workgroup meeting in Princeton, New Jersey, organized by NAACCR, the GIS subcommittee called for a systematic review of currently available, open-access cluster analysis software programs for cancer registries ([@b56-ehp0115-000165]). The discussion resulted in the publication of a detailed and systematic comparison of four cluster software packages (Crimestat, SaTScan, R-Geo, and GeoDa) ([@b4-ehp0115-000165]).

Methodologic guidance was also the impetus for a 2002 NCI meeting on "Current Practices in Spatial Data Analysis" in Bethesda, Maryland, convened to focus specifically on spatial data analysis. Proceedings from this meeting were published in three journal articles on cluster methodology that summarize the state of the art, discuss ongoing limitations, reinforce important caveats, and envision future developments ([@b12-ehp0115-000165]; [@b38-ehp0115-000165]; [@b64-ehp0115-000165]). Increased attention to cancer cluster methodologies represents a significant advancement in its own right; however, published recommendations for method selection vary, and the need for extensive systematic comparisons of different approaches remains ([@b38-ehp0115-000165]; [@b95-ehp0115-000165]; [@b97-ehp0115-000165]). Although some studies have already examined circumstance-appropriate applications for these methods ([@b35-ehp0115-000165]; [@b80-ehp0115-000165]), additional studies of this nature should allow for clearer guidelines on methods usage for the epidemiologist and other disease cluster investigators.

Combining cluster methodologies with GIS
----------------------------------------

Cluster analysis has been further bolstered by the incorporation of GIS into the cancer cluster approach. Basic GIS tools are now being used routinely to depict and display potential cancer clusters in visually compelling ways, for example, the NCI Atlas of Cancer Mortality for the United States (<http://www3.cancer.gov/atlasplus/>; [@b60-ehp0115-000165]). Recently, more complicated applications for GIS have included the active surveillance of cancer data to detect cancer clustering, a venture requiring coordinated implementation of GIS mapping and statistics-based spatiotemporal cluster analyses ([@b54-ehp0115-000165]; [@b73-ehp0115-000165]; [@b79-ehp0115-000165]).

However, unlike infectious diseases, which are relatively limited in time and space, chronic diseases such as cancer create analytical complexities not readily accommodated by current conventional GIS techniques and software packages ([@b38-ehp0115-000165]; [@b42-ehp0115-000165]). Moreover, issues concerning the accuracy and quality of data, metadata standards, inconsistent resolution of data points, aggregated data usage, and issues of privacy and confidentiality have yet to be fully resolved ([@b28-ehp0115-000165]; [@b38-ehp0115-000165]; [@b53-ehp0115-000165]; [@b63-ehp0115-000165]; [@b94-ehp0115-000165]).

Extensive discussions about the use of GIS in disease cluster analyses were held at the 1998 National Conference on GIS in Public Health in San Diego, California ([@b6-ehp0115-000165]; [@b69-ehp0115-000165]) and the 2002 North American Association of Central Cancer Registries GIS Workgroup meeting in Princeton, New Jersey ([@b55-ehp0115-000165]). Critics of the current use of GIS in cluster analysis note that this technology was originally developed for business purposes to generate static "snapshots" of locational information ([@b87-ehp0115-000165]). They suggest that this approach would be more useful in investigating the etiology of chronic diseases if it were reengineered to evaluate geographic locations in a dynamic time series ([@b38-ehp0115-000165]; [@b74-ehp0115-000165]). Thus, while GIS technology gains momentum in cluster investigations and is increasingly used for cancer registries and by cluster responders, new developments such as including more systematic approaches to cluster investigations, improved accuracy in data acquisition, and consideration of genetic susceptibility may be necessary to achieve optimal results ([@b38-ehp0115-000165]; [@b64-ehp0115-000165]; [@b69-ehp0115-000165]).

Conclusions
===========

Cancer cluster investigations occasionally have led to the discovery of important pathways in the etiology of specific cancers, such as with angiosarcoma ([@b98-ehp0115-000165]), lung cancer ([@b90-ehp0115-000165]), Kaposi sarcoma ([@b16-ehp0115-000165], [@b17-ehp0115-000165]), vaginal clear-cell carcinoma ([@b33-ehp0115-000165]), bladder cancer ([@b91-ehp0115-000165]), and scrotal cancer ([@b65-ehp0115-000165]). However, it is important to note that the majority of these studies that yielded etiologic information were studies of occupational, drug-induced, or infectious pathogenic exposure rather than studies of environmental exposure ([@b13-ehp0115-000165]; [@b32-ehp0115-000165]). Nonetheless, in some cases, geographic clusters with suspected environmental etiology warrant follow-up ([@b96-ehp0115-000165]). Cluster response is appropriate public health practice, but resources must be used efficiently and wisely. Responses to cluster inquiries include addressing community concerns, providing community education, and informing the community about the progress of investigations and/or exposure assessments.

Recently, a paradigm shift in cluster response has taken place: as analytic methods improve, exposure assessment using biologic sampling is now more commonly employed as part of the public health response ([@b27-ehp0115-000165]). Consequently, significant environmental exposure information may be obtained as well as an increased potential for detection of environment and disease relationships. Now that baseline human exposure data are available from the "Third National Report on Human Exposure to Environmental Chemicals" ([@b24-ehp0115-000165]), results from biomonitoring investigations may be much more meaningful.

The experience of federal, state, and local public health agencies with cancer cluster concerns and investigations has demonstrated the influence that mass media may have on the community concerning health, disease, and the environment. Although the underlying science of cancer cluster investigations is complex, the importance of providing this information to the public in a clear, balanced, and scientifically correct format cannot be overstated.

Future Directions
=================

The link to environmental exposures, whether perceived or actual, is an important issue that must be addressed. The many similarities across states in their efforts to respond to cancer cluster inquiries create the opportunity for state and federal agencies to better coordinate their efforts. An important role for the CDC is, and will continue to be, to facilitate communication among states and others, to provide assistance when appropriate, to provide increased access to relevant data, and to foster the development of new systems, tools, and approaches to cluster investigation.

This article is part of the mini-monograph "Cancer Cluster Activities at the Centers for Disease Control and Prevention."
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###### 

Recent CDC-sponsored cancer cluster activities in the United States.

  Year         CDC cluster activities
  ------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  2002         CCPITS
  2002--2003   Survey of state protocols in cancer clusters (56 states/territories)
  2002         State site visits (AZ, OH, NJ, MA)
  2003         State and Federal Technical Capacity Building Workshop: Response to Cancer Clusters with Suspected Environmental Etiology (CA, FL, GA, MA, MD, MN, NY, SC, TX, WA; [@b20-ehp0115-000165])
  2003         Electronic listserver (185 participants; [@b21-ehp0115-000165])
  2002--2003   Survey of media reports on cancer clusters
  2001--2003   Assistance to Nevada State Department of Health; Cross Sectional Exposure Assessment of Case Children with Leukemia and a Reference Population in Churchill County, Nevada ([@b19-ehp0115-000165]; [@b72-ehp0115-000165])
  2003--2005   Assistance to the CCHD and the Arizona Department of Health Services; Biosampling of Children with Leukemia plus a Comparison Population in Sierra Vista, Arizona ([@b15-ehp0115-000165])

###### 

Software available for disease cluster analysis.

  Software name/package                                         Fee   GIS functions   Website                                                                                                                     Reference
  ------------------------------------------------------------- ----- --------------- --------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------
  CLUSTER 3.1                                                   Yes   None            <http://www.atsdr.cdc.gov/HS/cluster.html>                                                                                  [@b7-ehp0115-000165]; [@b31-ehp0115-000165]
  ClusterSeer                                                   Yes   Compatible      <http://www.terraseer.com/products/clusterseer.html>                                                                        [@b37-ehp0115-000165]; [@b81-ehp0115-000165]
  CrimeStat 3.0                                                 Yes   None            <http://www.icpsr.umich.edu/NACJD/crimestat.html>                                                                           [@b47-ehp0115-000165]
  DMAP[a](#tfn1-ehp0115-000165){ref-type="table-fn"}            No    Built in        <http://www.uiowa.edu/~gishlth/DMAP/>                                                                                       [@b89-ehp0115-000165]
  EpiAnalyst                                                    Yes   Compatible      <http://www.phrl.org/REGS/Info%20EpiAnalyst.htm>                                                                            [@b68-ehp0115-000165]
  GeoDa 0.9.5-1[a](#tfn1-ehp0115-000165){ref-type="table-fn"}   No    Built in        <http://www.geoda.uiuc.edu/default.php>                                                                                     [@b3-ehp0115-000165]; [@b5-ehp0115-000165]
  Point Pattern Analysis (PPA)                                  No    None            <http://www.nku.edu/~longa/cgi-bin/cgi-tcl-examples/generic/ppa/ppa.cgi>; <http://www-rohan.sdsu.edu/~aldstadt/tools.htm>   [@b1-ehp0115-000165]
  R-Geo 2.0.0[a](#tfn1-ehp0115-000165){ref-type="table-fn"}     No    Compatible      <http://cran.r-project.org>                                                                                                 [@b66-ehp0115-000165]
  S+SpatialStats                                                Yes   Compatible      <http://www.insightful.com>                                                                                                 [@b36-ehp0115-000165]
  SaTScan[a](#tfn1-ehp0115-000165){ref-type="table-fn"}         No    None            <http://www.satscan.org>                                                                                                    [@b45-ehp0115-000165]; [@b76-ehp0115-000165]
  SpaceStat                                                     Yes   Compatible      <http://www.terraseer.com/products/spacestat.html>                                                                          [@b2-ehp0115-000165]

Features of these software packages are compared in a review by [@b4-ehp0115-000165].

[^1]: The authors declare they have no competing financial interests.
